Literature DB >> 17393104

Increased expression of PI-3K in asthmatic rat T lymphocytes.

Jin Liu1, Shixin Zhou, Shengdao Xiong, Yongjian Xu, Zhenxiang Zhang, Weining Xiong.   

Abstract

In order to explore the expression of PI-3K in T lymphocytes of asthmatic rats and the relationship between PI-3K and activation of T lymphocytes, 24 Wistar rats were randomly divided into 4 groups: normal control group, asthmatic one-week group, asthmatic two-week group and asthmatic four-week group. T cells were purified from blood of each rat and the expression of PI-3K was observed by immunocytochemical fluorescence staining, the semiquantitative fluorescence intensity was measured by HPIAS-2000 analytic software, and the expression of IL-4 in supernatants was detected by ELISA. The results showed that the fluorescence intensity of T lymphocytes in asthmatic groups was significantly higher than that in normal control (P<0.001), indicating that the expression of PI-3K in T lymphocytes of asthmatic rats was significantly higher than that in those of normal controls, and the difference between acute and chronic stage asthmatic groups was significant (P<0.05). The expression levels of IL-4 protein in supernatants of asthmatic T lymphocytes were significantly higher than those in the normal controls (P<0.05). There was a significant positive correlation between the expression of PI-3K in T lymphocytes and the IL-4 protein expression in supernatants (r=0.583, P<0.01). It was suggested that PI-3K signal pathway may participate in the processes of activation and other cytological effects of asthmatic T lymphocytes, thus may play an important roles in the pathogenesis of asthma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393104     DOI: 10.1007/s11596-007-0110-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

Review 1.  PI3K in lymphocyte development, differentiation and activation.

Authors:  Klaus Okkenhaug; Bart Vanhaesebroeck
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.

Authors:  Leonard J Appleman; Andre A F L van Puijenbroek; Kirstin M Shu; Lee M Nadler; Vassiliki A Boussiotis
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

3.  c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis.

Authors:  A Lauder; A Castellanos; K Weston
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

4.  PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF.

Authors:  G G Choudhury; C Karamitsos; J Hernandez; A Gentilini; J Bardgette; H E Abboud
Journal:  Am J Physiol       Date:  1997-12

5.  Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway.

Authors:  Saori Sato; Naoya Fujita; Takashi Tsuruo
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

Review 6.  Phosphoinositide 3-kinase in T cell activation and survival.

Authors:  K Okkenhaug; A Bilancio; J L Emery; B Vanhaesebroeck
Journal:  Biochem Soc Trans       Date:  2004-04       Impact factor: 5.407

7.  Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia.

Authors:  Ligia Chialda; Meixia Zhang; Kay Brune; Andreas Pahl
Journal:  Respir Res       Date:  2005-04-15

8.  Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT.

Authors:  Shigeharu Myou; Alan R Leff; Saori Myo; Evan Boetticher; Jiankun Tong; Angelo Y Meliton; Jie Liu; Nilda M Munoz; Xiangdong Zhu
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

9.  CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function.

Authors:  Pushpa Pandiyan; Dagmar Gärtner; Osman Soezeri; Andreas Radbruch; Klaus Schulze-Osthoff; Monika C Brunner-Weinzierl
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.